Mommaerts Maurice Y
Face Ahead® Surgicenter, Belgium and Ziekenhuis aan de Stroom, Campus GZA, B-2018, Antwerp, Belgium.
J Stomatol Oral Maxillofac Surg. 2024 Dec 19:102206. doi: 10.1016/j.jormas.2024.102206.
This expert opinion presents provisional guidelines for addressing complications associated with Additively Manufactured Subperiosteal Jaw Implants (AMSJI®) in patients with severe maxillary atrophy. AMSJI®'s custom design, supported by finite element analysis (FEA), allows precise placement that avoids critical anatomical structures and minimizes complications relative to alternative solutions.
Data were gathered through firsthand experiences, direct communications, two structured surveys and insights from international workgroup meetings.
Minor complications, such as soft tissue recession with inflammation, can be managed through thorough patient selection and early intervention. Severe complications, such as ascending infections and mechanical issues (e.g., fractures of implant components), have been rare. Compared to zygomatic implants and bone grafting, AMSJI® demonstrates a favorable safety profile. Zygomatic implants may lead to severe issues like orbital cellulitis and diplopia, while bone grafting risks include graft resorption, loss, and donor site complications. To mitigate risks, selecting patients carefully and ensuring diligent follow-up are critical, especially in those with risk factors like smoking or bruxism. Improved imaging, planning, and FEA have further contributed to minimizing complications, reinforcing AMSJI®'s role in complex maxillary reconstructions and implant-supported prosthetics.
AMSJI® demonstrates high success rates but requires meticulous risk management. Key strategies involve carefully candidates by excluding those who are smokers, immunocompromised, or non-compliant, or diabetics with a history of infectious complications. Additionally, strict adherence to oral hygiene protocols is essential to optimize outcomes and minimize risks.Proactive management in these areas is crucial to optimize outcomes, ensure implant longevity, and support successful prosthetic rehabilitation.
本专家意见提出了处理严重上颌骨萎缩患者使用增材制造的骨膜下颌骨植入物(AMSJI®)相关并发症的临时指南。AMSJI®的定制设计在有限元分析(FEA)的支持下,能够实现精确放置,避免关键解剖结构,并相对于其他替代方案将并发症降至最低。
通过第一手经验、直接沟通、两项结构化调查以及国际工作组会议的见解收集数据。
轻微并发症,如伴有炎症的软组织退缩,可以通过全面的患者选择和早期干预来处理。严重并发症,如上行性感染和机械问题(如植入物部件骨折)则较为罕见。与颧骨植入物和骨移植相比,AMSJI®显示出良好的安全性。颧骨植入物可能导致严重问题,如眼眶蜂窝织炎和复视,而骨移植的风险包括移植骨吸收、丢失和供区并发症。为降低风险,仔细选择患者并确保勤勉随访至关重要,尤其是对于有吸烟或磨牙症等风险因素的患者。改进的成像、规划和有限元分析进一步有助于将并发症降至最低,强化了AMSJI®在复杂上颌骨重建和种植体支持修复中的作用。
AMSJI®显示出高成功率,但需要细致的风险管理。关键策略包括通过排除吸烟者、免疫功能低下者、不依从者或有感染并发症病史的糖尿病患者来谨慎挑选候选人。此外,严格遵守口腔卫生方案对于优化结果和降低风险至关重要。在这些领域进行积极管理对于优化结果、确保种植体寿命以及支持成功的修复性康复至关重要。